Cite
PIN20 Prevalence Of Hepatic Outcomes Among Commercially-Insured Patients Diagnosed With Chronic Hepatitis C Virus
MLA
Scaife, J., et al. “PIN20 Prevalence Of Hepatic Outcomes Among Commercially-Insured Patients Diagnosed With Chronic Hepatitis C Virus.” Value in Health, no. 3, p. A82. EBSCOhost, https://doi.org/10.1016/j.jval.2013.03.379. Accessed 15 Dec. 2024.
APA
Scaife, J., Kuti, E., Acampa, L., Million, R., Miyasato, G., Wang, Z., Sander, S., Sanchez, H., & Kokkotos, F. K. (n.d.). PIN20 Prevalence Of Hepatic Outcomes Among Commercially-Insured Patients Diagnosed With Chronic Hepatitis C Virus. Value in Health, 3, A82. https://doi.org/10.1016/j.jval.2013.03.379
Chicago
Scaife, J., E. Kuti, L. Acampa, R. Million, G. Miyasato, Z. Wang, S. Sander, H. Sanchez, and F.K. Kokkotos. 2024. “PIN20 Prevalence Of Hepatic Outcomes Among Commercially-Insured Patients Diagnosed With Chronic Hepatitis C Virus.” Value in Health, no. 3: A82. Accessed December 15. doi:10.1016/j.jval.2013.03.379.